ArticleMethods in molecular biology (Clifton, N.J.)2026
Utilizing Protein Bioinformatics to Delve Deeper into Immunopeptidomic Datasets with AIMS: An Automated Immune Molecule Separator.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunopeptidomics is a growing subfield of proteomics that has the potential to shed new light on a long-neglected aspect of adaptive immunology: a comprehensive understanding of the peptides presented by major histocompatibility complexes (MHC) to T cells. As the field of immunopeptidomics continues to grow and mature, a parallel expansion in the methods for extracting quantitative features of these peptides is necessary. Currently, massive experimental efforts to isolate a given immunopeptidome are summarized in tables and pie charts or, worse, entirely thrown out in favor of singular peptides of interest. Ideally, an unbiased approach would dive deeper into these large proteomic datasets, identifying sequence-level biochemical signatures inherent to each individual dataset and the given immunological niche. This chapter will outline the steps for a powerful approach to such analysis, utilizing the Automated Immune Molecule Separator (AIMS) software for the characterization of immunopeptidomic datasets. AIMS is a flexible tool for the identification of biophysical signatures in peptidomic datasets, the elucidation of nuanced differences in repertoires collected across tissues or experimental conditions, and the generation of machine learning models for future applications to classification problems. In learning to use AIMS, readers of this chapter will receive a broad introduction to the field of protein bioinformatics and its utility in the analysis of immunopeptidomic datasets and other large-scale immune repertoire datasets.
Indexed as
Identifiers
41085626What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.